SAN CARLOS, Calif.-- October 14, 2026 -- Altay Therapeutics, Inc., a biotechnology company developing novel small molecule inhibitors of transcription factors, today announced the completion of a $37 million Series...
Sean McCarthy will participate on a panel at the BIO International Convention in San Diego, CA titled "New Models for External Innovation by Pharma"
News | 06. 17. 2008
